SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WTDEC who wrote (23121)7/14/1998 12:49:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
Speaking of Heard on Wall Street, this afternoon the Wall Street Business report on CBS radio mentioned Viagra and its blockbuster sales. The report indicated that companies were now beginning to target female sexual dysfunction. Several companies (no names mentioned) had drugs that were just entering clinical trials and companies were preparing for filing IND's. The only drug mentioned was testosterone, which was known to increase sexual appetite but had side effects.

As you know, LGND claims to have the largest androgen program in the world. The program targets men and women's health and is designed to address "unmet needs" through increased efficacy and decreased side effects. LGND's animal data is quite extensive and impressive.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext